When available, the Online Course format is included with the hard copy, eBook, or audio book formats!
Release Date: June 13, 2017
Expiration Date: June 13, 2019
Emerging and re-emerging viral infections, which include outbreaks of previously unknown pathogens or new strains of known viruses, continue to pose significant threats and challenges to human well-being globally. The convergence of these known and other less known viruses contributes to a variety of factors that enables them to expand their spectrum of activity. Such factors include mutations, the development of environmental conditions that help to spread the disease agents, the availability of an ever increasing range of susceptible hosts, and the lack of effective laboratory detection testing methods. An awareness of these factors together with current knowledge of their existence and effects is essential to control and prevention.
Adding to the dangers posed by emerging viral diseases is the appearance of new strains of many known pathogens in more virulent forms. Widespread travel, the globalization of food supplies, and the increasing overlap between the environments of humans and lower animals give viruses, as well as other microorganisms, rapid and easy access to new populations. Unfortunately, newly recognized pathogens are accelerating their distribution by spreading faster and further, affecting the security of nations and the global economy.
This intermediate-level course is geared toward all levels and disciplines of healthcare and public health professionals. The course provides information about recently discovered and reoccurring viruses. Knowledge of the origin, pathogenesis, and diagnosis of these viruses may aid in reducing the prevalence of the infections they cause.
- Distinguish among diseases that are sporadic, endemic, or pandemic in occurrence.
- Discuss the common causes and features of emerging diseases.
- Describe the general properties of viruses.
- Describe the general characteristic properties, virology, means of transmission, epidemiological
factors, clinical features, populations at risk, treatment, prevention, and control of:
• influenza viruses,
• human bocavirus,
• Nipah and Hendra viruses,
• severe acute respiratory syndrome,
• Middle East respiratory syndrome,
• viral hemorrhagic fevers and Ebola, and
• vector-borne viruses.
Traci Marin, PhD, MPH, RRT, RPGST, is an associate research professor and program director in the Department of Cardiopulmonary Sciences, Schools of Allied Health and Medicine at Loma Linda University and Program Director of Doctoral Studies in Health Sciences at Trident University. She is also an adjunct researcher and advisor in the Department of Medicine at the University of California, San Diego, as well as the founder of Tranquility Community Health. Dr. Marin received a PhD in biochemistry and molecular biology from the University of California, Riverside; an MPH in epidemiology and biostatistics from Loma Linda University; a bachelor’s degree in emergency medical care from Loma Linda University; and an associate’s degree in respiratory therapy from Victor Valley College.
- Contact hours will be awarded for up to one (1) year from date of purchase or through the expiration date indicated above, whichever date comes first.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
- Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.